Sana Biotechnology Inc vs Veritone Inc — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while Veritone Inc trades at $1.13 (market cap $97.60M). The key difference: Sana Biotechnology Inc is far larger — about 9× Veritone Inc's market cap, and Sana Biotechnology Inc is trading nearer its 52-week high, Veritone Inc nearer its low. Which is the better fit depends on your goals.
| SANA | VERI | |
|---|---|---|
Market Cap | $873.84M | $97.60M |
Sector | Health | Technology |
52-Week High | $5.92 | $8.39 |
52-Week Low | $2.68 | $1.02 |
Enterprise Value | $848.03M | $129.63M |
Trailing returns across standard periods
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →Veritone is a leading provider of enterprise AI software and solutions, centered on its proprietary AI operating system, aiWARE™. The platform orchestrates a vast ecosystem of machine learning models to transform unstructured data—such as audio, video, and text—into actionable intelligence. Serving the media, entertainment, and public sectors, Veritone is a critical infrastructure partner for organizations looking to monetize data archives and operationalize AI at scale.
Read more on VERI →